Dr. Brietzke is interested in the investigation neurobiology of mood disorders, with a special emphasis on immune-inflammatory abnormalities, metabolic changes and domains of psychopathology, such as anhedonia and cognitive decline. I am also focused on the application of these findings to the development of innovative treatments for bipolar disorder and depression.